MLL1 (mixed lineage leukemia) protein plays important roles in normal and malignant hematopoiesis by regulating the expression of a specific group of genes. It has been proposed that MLL1 affects gene expression through effecting histone H3 methylation on lysine 4, and through interactions with other chromatin modifying activities such histone acetyltransferases. The objectives of the proposed research are to understand the fundamental mechanisms of how MLL1 mediated transcription activation from compacted chromatin is achieved through concerted actions of different chromatin remodeling activities and to study the molecular basis for its well-described antagonism against Polycomb group proteins, which are critical components for epigenetic regulation of gene repression. The proposed research emphasizes on the regulation of MLL1 enzymatic activities in the complex, on the recruitment mechanism targeting MLL1 complex to promoters, and on downstream events that transduce the histone modifications to transcription activation, through the specific docking of downstream effectors. We will take clues from the structural analyses and the genomic mapping results of target genes, employ well-established methods such as MLL1 complex reconstitution and the recombinant chromatin-templated in vitro transcription assays for detailed mechanistic dissection of the series events leading to transcriptional activation. The in vitro studies will be complemented with in vivo approaches designed to guide and validate results obtained from cell-free system. The proposed work will significantly advance our knowledge for the functions of MLL1 in important processes such as embryonic development, hematopoiesis, cell fate determination and cell cycle control through transcriptional regulation of specific genes. Given that MLL1 mutations are commonly found in human myeloid and lymphoid acute leukemias, the proposed study also bears significance in elucidating mechanisms for leukemogenesis and thus, lays the foundation for advances in disease diagnosis, treatment, and prevention. This project matches best with the mission of national institute of general medical science (NIGMS) and is budgeted at $1,250,000 for a five-year period.

Public Health Relevance

Genetic changes of mixed lineage leukemia protein (MLL1) account for ~10% acute leukemia in adult and for ~70% infant leukemia in the population. The most notable signature for MLL-related leukemia is the change of specific gene expression pattern. This project is to understand the fundamental mechanism for these changes and thus, the cause of the disease. It will set up the foundation for potential medical interference in the future.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Molecular Genetics C Study Section (MGC)
Program Officer
Carter, Anthony D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Schools of Medicine
Ann Arbor
United States
Zip Code
Sun, Yuqing; Zhou, Bo; Mao, Fengbiao et al. (2018) HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis. Cancer Cell 34:643-658.e5
Gupta, Ankit; Xu, Jing; Lee, Shirley et al. (2018) Facile target validation in an animal model with intracellularly expressed monobodies. Nat Chem Biol 14:895-900
Khoa, Le Tran Phuc; Dou, Yali (2017) Phosphoproteomics links glycogen synthase kinase-3 to RNA splicing. J Biol Chem 292:18256-18257
Zhang, Hui; Dou, Yali (2017) Reprogram Murine Epiblast Stem Cells by Epigenetic Inhibitors. Bio Protoc 7:
Albert, Lea; Xu, Jing; Wan, Ruiwei et al. (2017) Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia. Chem Sci 8:4612-4618
Wang, Weimin; Kryczek, Ilona; Dostál, Lubomír et al. (2016) Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer. Cell 165:1092-1105
Li, Yanjing; Han, Jianming; Zhang, Yuebin et al. (2016) Structural basis for activity regulation of MLL family methyltransferases. Nature 530:447-52
Xu, Jing; Li, Li; Xiong, Jie et al. (2016) MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program. Cell Discov 2:16008
Zhou, Bo; Wang, Jingya; Lee, Shirley Y et al. (2016) PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity. Mol Cell :
Nagarsheth, Nisha; Peng, Dongjun; Kryczek, Ilona et al. (2016) PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Res 76:275-82

Showing the most recent 10 out of 29 publications